Albendazole versus metronidazole in the treatment of adult giardiasis: a randomized, double-blind, clinical trial

References

• Escobedo AA, Cañete R, Núñez FA. Risk factors and clinical features associated with intestinal parasitic infections in children from San Juan y Martínez, Pinar del Río, Cuba. West Indian Med J 2008;57:377-82
   PubMed Web of Science ®Google Scholar
• Solaymani-Mohammadi S, Genkinger JM, Loffredo CA, et al. A meta-analysis of the effectiveness of albendazole compared with metronidazole as treatments for infections with giardia duodenalis. PLoS Negl Trop Dis 2010;4:e682. doi:10.1371/journal.pntd.0000682
   PubMed Web of Science ®Google Scholar
• Savioli L, Smith H, Thompson A. Giardia and Cryptosporidium join the “Neglected Diseases Initiative”. Trends Parasitol 2006;22:203-8
   PubMed Web of Science ®Google Scholar
• Lalle M. Giardiasis in the post genomic era: treatment, drug resistance and novel therapeutic perspectives. Infect Disord Drug Targets 2010;10:283-94
   PubMedGoogle Scholar
• Plutzer J, Ongerth J, Karanis P. Giardia taxonomy, phylogeny and epidemiology: facts and open questions. Int J Hyg Environ Health 2010;213:321-33
   PubMed Web of Science ®Google Scholar
• Carranza PG, Lujan HD. New insights regarding the biology of Giardia lamblia. Microbes Infect 2010;12:71-80
   PubMed Web of Science ®Google Scholar
• Cañete R, González ME, Almirall P, et al. Infección por giardia y giardiosis. Rev Panam Infectol 2004;6:39-46
   Google Scholar
• Escobedo AA, Cimerman S. Giardiasis: a pharmacotherapy. Expert Opin Pharmacother 2007;8:1885-902
   PubMed Web of Science ®Google Scholar
• Cañete R, Escobedo AA, Almirall P, et al. Mebendazole in parasitic infections other than those caused by soil-transmitted helminths. Trans R Soc Trop Med Hyg 2009;103:437-42
   PubMed Web of Science ®Google Scholar
• Tian HF, Chen B, Wen JF. Giardiasis, drug resistance, and new target discovery. Infect Disord Drug Targets 2010;10:295-302
   PubMedGoogle Scholar
• Müller J, Wastling J, Sanderson S, et al. A novel Giardia lamblia nitroreductase, GlNR1, interacts with nitazoxanide and other thiazolides. Antimicrob Agents Chemother 2007;51:1979-86
   PubMed Web of Science ®Google Scholar
• Hausen MA, de Oliveira RP, Gadelha AP, et al. Giardia lamblia: a report of drug effects under cell differentiation. Parasitol Res 2009;105:789-96
   PubMed Web of Science ®Google Scholar
• Keiser J, Utzinger J. Efficacy of current drugs against soil-transmitted helminth infections: systematic review and meta-analysis. JAMA 2008;299:1937-48
   PubMed Web of Science ®Google Scholar
• Geary TG, Woo K, McCarthy JS, et al. Unresolved issues in anthelmintic pharmacology for helminthiases of humans. Int J Parasitol 2010;40:1-13
   PubMed Web of Science ®Google Scholar
• Uneke CJ. Soil transmitted helminth infections and schistosomiasis in school age children in sub-Saharan Africa: efficacy of chemotherapeutic intervention since World Health Assembly Resolution 2001. Tanzan J Health Res 2010;12:86-99
   PubMedGoogle Scholar
• Sudomo M, Chayabejara S, Duong S, et al. Elimination of lymphatic filariasis in Southeast Asia. Adv Parasitol 2010;72:205-33
   PubMed Web of Science ®Google Scholar
• Tian HF, Chen B, Wen JF. Giardiasis, drug resistance, and new target discovery. Infect Disord Drug Targets. 2010;10:295-302
   PubMedGoogle Scholar
• Cedillo-Rivera R, Muñoz O. In vitro susceptibility of Giardia lamblia to albendazole, mebendazole and other chemotherapeutic agents. J Med Microbiol 1992;37:221-4
   PubMed Web of Science ®Google Scholar
• Katiyar SK, Gordon VR, McLaughlin GL, et al. Antiprotozoal activities of benzimidazoles and correlations with beta-tubulin sequence. Antimicrob Agents Chemother 1994;38:2086-90
   PubMed Web of Science ®Google Scholar
• Chávez B, Cedillo-Rivera R, Martínez-Palomo A. Giardia lamblia: ultrastructural study of the in-vitro effect of benzimidazoles. J Parasitol 1992;39:510-15
   Google Scholar
• Morgan UM, Reynoldson JA, Thompson RC. Activities of several benzimidazoles and tubulin inhibitors against Giardia spp. in vitro. Antimicrob Agents Chemother 1993;37:328-31
   PubMed Web of Science ®Google Scholar
• Katelaris PH, Naeem A, Farthing MJ. Activity of metronidazole, azithromycin and three benzimidazoles on Giardia lamblia growth and attachment to a human intestinal cell line. Aliment Pharmacol Ther 1994;8:187-92
   PubMed Web of Science ®Google Scholar
• Reynoldson JA, Thompson RC, Meloni BP. In vivo efficacy of albendazole against Giardia duodenalis in mice. Parasitol Res 1991;77:325-28
   PubMed Web of Science ®Google Scholar
• Morch K, Hanevik K, Rortveit G, et al. High rate of fatigue and abdominal symptoms 2 years after an outbreak of giardiasis. Trans R Soc Trop Med Hyg 2009;103:530-2
   PubMed Web of Science ®Google Scholar
• Morken MH, Valeur J, Norin E, et al. Antibiotic or bacterial therapy in post-giardiasis irritable bowel syndrome. Scand J Gastroenterol 2009;44:1296-303
   PubMed Web of Science ®Google Scholar
• Cañete R, Rivas DE, Escobedo AA, et al. A randomized, controlled, open-label trial evaluating the efficacy and safety of chloroquine in the treatment of giardiasis in children. West Indian Med J 2010;59:607-11
   PubMed Web of Science ®Google Scholar
• González ME, Cañete R, Álvarez G, et al. Nitazoxanide for the treatment of Giardia duodenalis infection: a comparative trial with secnidazole. Türk Hijyen ve Deneysel Biyoloji Dergisi 2010;67(3):113-9
   Google Scholar
• Cañete R, Escobedo AA, González ME, et al. A randomised, controlled, open-label trial of a single day of mebendazole versus a single dose of tinidazole in the treatment of giadiasis in children. Curr Med Res Opin 2006;22:2131-6
   PubMed Web of Science ®Google Scholar
• Cañete R, Escobedo AA, González ME, et al. Randomized clinical study of five days therapy with mebendazole compared to quinacrine in the treatment of symptomatic giardiasis in children. World J Gastroenterol 2006;12:6366-70
   PubMed Web of Science ®Google Scholar
• Escobedo AA, Cañete R, González ME, et al. A randomized trial comparing mebendazole and secnidazole for the treatment of giardiasis. Ann Trop Med Parasitol 2003;97:499-504
   PubMed Web of Science ®Google Scholar
• Alizadeh A, Ranjbar M, Kashani KM, et al. Albendazole versus metronidazole in the treatment of patients with giardiasis in the Islamic Republic of Iran. East Mediterr Health J 2006;12:548-54
   PubMedGoogle Scholar
• Karabay O, Tamer A, Gunduz H, et al. Albendazole versus metronidazole treatment of adult giardiasis: an open randomized clinical study. World J Gastroenterol 2004;10:1215-17
   PubMed Web of Science ®Google Scholar
• Yereli K, Balcioglu IC, Ertan P, et al. Albendazole as an alternative therapeutic agent for childhood giardiasis in Turkey. Clin Microbiol Infect 2004;10:527-9
   PubMed Web of Science ®Google Scholar
• Misra PK, Kumar A, Agarwal V, et al. A comparative clinical trial of albendazole versus metronidazole in children with giardiasis. Indian Pediat 1995;32:779-82
   PubMedGoogle Scholar
• Hall A, Nahar Q. Albendazole as a treatment for infections with Giardia duodenalis in children in Bangladesh. Trans R Soc Trop Med Hyg 1993;87:84-6
   PubMed Web of Science ®Google Scholar
• Romero-Cabello R, Robert L, Muñoz-García R, et al. Randomized study comparing the safety and efficacy of albendazole and metronidazole in the treatment of giardiasis in children. Rev Latinoam Microbiol 1995;37:315-23
   PubMedGoogle Scholar
• Islamova ZhI, Syrov VN, Khushbaktova ZA, et al. The efficacy of ecdystene versus metronidazole in the treatment of lambliasis. Med Parazitol (Mosk) 2010;(2):14-7
   PubMedGoogle Scholar